Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18044
Abstract: a peptide a key regulator of iron in an hepcidin levels can restricted erythro-poiesis and anaemia. myeloproliferative neoplasm (MPN) in we in 99 patients 49 and (SMF) Twenty- four of these patients ruxolitinib a JAK1/2… read more here.
Keywords: hepcidin elevated; secondary myelofibrosis; elevated primary; primary secondary ... See more keywords